Trial reportJournal of cardiothoracic surgery2019
Clinical observation of modified gastric tube in middle and lower thoracic esophageal carcinoma surgery.
Trial report in Journal of cardiothoracic surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.
- Chylous leakage after esophagectomy for esophageal cancer: a systematic review.Journal of cardiothoracic surgery · 2024Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA clinical case-control study was conducted to analyze the short-term efficacy of modified gastric tube in surgery for middle (mid)- and lower- thoracic esophageal carcinoma compared with the conventional gastric tube and its effect on postoperative pulmonary function.
methodsA total of 70 patients with mid- and lower-thoracic esophageal cancer who underwent esophagectomy between October 2012 and September 2018 in our hospital were recruited in the study. They were randomly divided into a modified gastric tube group (n = 35) and a conventional gastric tube group (n = 35). The operation time, intraoperative blood loss, number of intraoperative lymph node dissection, gastrointestinal decompression time and postoperative hospital stay were recorded. The operation results and complications were recorded, and the pulmonary function was recorded at 3 days before surgery and 6 weeks after surgery.
resultsThe operation time in the modified gastric tube group was significantly lower than that in the gastric tube group (P < 0.05). There were no anastomotic leakage or death occurred in the modified gastric tube group. There was 1 case of anastomotic leakage in the conventional gastric tube group. The pulmonary function in both groups was improved at 6 weeks after surgery, but there was no significant difference between both groups (P > 0.05).
conclusionModified gastric tube has a good clinical application value compared with gastric tube for patients with mid- and lower-thoracic esophageal cancer. It is easy and safe, and can shorten the operation time without aggravation of pulmonary function after surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.